The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein.

The transmissible spongiform encephalopathies are fatal neurodegenerative diseases that are associated with the accumulation of a protease-resistant form of the cellular prion protein (PrP). Although PrP is highly conserved and widely expressed in vertebrates, its function remains a matter of speculation. Indeed PrP null mice develop normally and are healthy. Recent results show that PrP binds to nucleic acids in vitro and is found associated with retroviral particles. Furthermore, in mice the scrapie infectious process appears to be accelerated by MuLV replication. These observations prompted us to further investigate the interaction between PrP and nucleic acids, and compare it with that of the retroviral nucleocapsid protein (NC). As the major nucleic acid-binding protein of the retroviral particle, NC protein is tightly associated with the genomic RNA in the virion nucleocapsid, where it chaperones proviral DNA synthesis by reverse transcriptase. Our results show that the human prion protein (huPrP) functionally resembles NCp7 of HIV-1. Both proteins form large nucleoprotein complexes upon binding to DNA. They accelerate the hybridization of complementary DNA strands and chaperone viral DNA synthesis during the minus and plus DNA strand transfers necessary to generate the long terminal repeats. The DNA-binding and strand transfer properties of huPrP appear to map to the N-terminal fragment comprising residues 23 to 144, whereas the C-terminal domain is inactive. These findings suggest that PrP could be involved in nucleic acid metabolism in vivo.

[1]  E. Stadtman,et al.  Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli. , 1968, Biochemistry.

[2]  S. Prusiner Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[3]  F. Barré-Sinoussi,et al.  HIV‐1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA. , 1989, The EMBO journal.

[4]  T. Sklaviadis,et al.  Potential retroviral RNAs in Creutzfeldt-Jakob disease , 1990, Journal of virology.

[5]  Stephen J. DeArmond,et al.  Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication , 1990, Cell.

[6]  R. Young,et al.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus , 1990, Journal of virology.

[7]  S. Prusiner,et al.  Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Chesebro,et al.  Normal and scrapie-associated forms of prion protein differ in their sensitivities to phospholipase and proteases in intact neuroblastoma cells , 1990, Journal of virology.

[9]  G. J. Raymond,et al.  The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. , 1991, The Journal of biological chemistry.

[10]  B. Roques,et al.  Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Bratosin-Guttman A new method for the routine spreading of DNA in protein-free conditions. , 1992, Journal of structural biology.

[12]  A. Aguzzi,et al.  Mice devoid of PrP are resistant to scrapie , 1993, Cell.

[13]  B. Roques,et al.  Trans-activation of the 5' to 3' viral DNA strand transfer by nucleocapsid protein during reverse transcription of HIV1 RNA. , 1993, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[14]  T. Sklaviadis,et al.  Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[15]  U. Ramsperger,et al.  p53‐catalyzed annealing of complementary single‐stranded nucleic acids. , 1993, The EMBO journal.

[16]  C. Burd,et al.  Conserved structures and diversity of functions of RNA-binding proteins. , 1994, Science.

[17]  G. J. Raymond,et al.  Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected] , 1994, Journal of virology.

[18]  J. Darlix,et al.  Transactivation of the minus‐strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. , 1994, The EMBO journal.

[19]  Douglas S. Portman,et al.  RNA annealing activities in HeLa nuclei. , 1994, The EMBO journal.

[20]  A. Akowitz,et al.  Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease. , 1994, Nucleic acids research.

[21]  D. Herschlag RNA Chaperones and the RNA Folding Problem (*) , 1995, The Journal of Biological Chemistry.

[22]  A. Akowitz,et al.  Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Roques,et al.  First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. , 1995, Journal of molecular biology.

[24]  Mary Lapadat-Tapolsky,et al.  Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1 , 1995, Nucleic Acids Res..

[25]  T. Formosa,et al.  Yeast Proteins Related to the p40/Laminin Receptor Precursor Are Essential Components of the 40 S Ribosomal Subunit (*) , 1996, The Journal of Biological Chemistry.

[26]  C. Gabus,et al.  Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. , 1997, Journal of molecular biology.

[27]  J. Mak,et al.  Primer tRNAs for reverse transcription , 1997, Journal of virology.

[28]  P E Wright,et al.  Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Loike,et al.  Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein , 1997, Nature Medicine.

[30]  F. Edenhofer,et al.  The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells , 1997, Nature Medicine.

[31]  G. Pesole,et al.  The 67-kDa laminin receptor originated from a ribosomal protein that acquired a dual function during evolution. , 1998, Molecular biology and evolution.

[32]  S. Prusiner,et al.  A transmembrane form of the prion protein in neurodegenerative disease. , 1998, Science.

[33]  D. Ficheux,et al.  The yeast Ty3 retrotransposon contains a 5′–3′ bipartite primer‐binding site and encodes nucleocapsid protein NCp9 functionally homologous to HIV‐1 NCp7 , 1998, The EMBO journal.

[34]  S. Dupuis,et al.  Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase , 1998, Nature Genetics.

[35]  S. Hornemann,et al.  Prion protein expression in different species: analysis with a panel of new mAbs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  F. Cohen,et al.  Prion Protein Biology , 1998, Cell.

[37]  S. L. Le Grice,et al.  Role of Post-transcriptional Modifications of Primer tRNALys,3 in the Fidelity and Efficacy of Plus Strand DNA Transfer during HIV-1 Reverse Transcription* , 1999, The Journal of Biological Chemistry.

[38]  R. Carp,et al.  Scrapie strain-specific interactions with endogenous murine leukaemia virus. , 1999, The Journal of general virology.

[39]  S. Ferrari,et al.  Proteasomal Degradation and N-terminal Protease Resistance of the Codon 145 Mutant Prion Protein* , 1999, The Journal of Biological Chemistry.

[40]  J. Brockes Topics in prion cell biology , 1999, Current Opinion in Neurobiology.

[41]  W. Surewicz,et al.  Membrane Environment Alters the Conformational Structure of the Recombinant Human Prion Protein* , 1999, The Journal of Biological Chemistry.

[42]  J. Bess,et al.  Molecular Requirements for Human Immunodeficiency Virus Type 1 Plus-Strand Transfer: Analysis in Reconstituted and Endogenous Reverse Transcription Systems , 1999, Journal of Virology.

[43]  J. Luban,et al.  Basic Residues in Human Immunodeficiency Virus Type 1 Nucleocapsid Promote Virion Assembly via Interaction with RNA , 2000, Journal of Virology.

[44]  Toshiko Tanaka,et al.  A Human Gene Coding for a Membrane-associated Nucleic Acid-binding Protein* , 2000, The Journal of Biological Chemistry.

[45]  J. Laplanche,et al.  Signal transduction through prion protein. , 2000, Science.

[46]  K Wüthrich,et al.  NMR solution structure of the human prion protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Jianhui Guo,et al.  Zinc Finger Structures in the Human Immunodeficiency Virus Type 1 Nucleocapsid Protein Facilitate Efficient Minus- and Plus-Strand Transfer , 2000, Journal of Virology.

[48]  C. Gabus,et al.  The Prion Protein Has RNA Binding and Chaperoning Properties Characteristic of Nucleocapsid Protein NCp7 of HIV-1* , 2001, The Journal of Biological Chemistry.